{"disease":{"id":"respiratory-distress-syndrome-in-the-newborn","name":"Respiratory distress syndrome in the newborn","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":10,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"colfosceril-palmitate","indication_name":"Respiratory distress syndrome in the newborn","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"L-Dipalmitoyl Lecithin","generic_name":"COLFOSCERIL PALMITATE","company_name":"GSK","drug_phase":"marketed","molecular_target":"","drug_class":"colfosceril palmitate","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"calfactant","indication_name":"Respiratory distress syndrome in the newborn","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Infasurf","generic_name":"CALFACTANT","company_name":"ONY","drug_phase":"marketed","molecular_target":"","drug_class":"Surfactant [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"beractant","indication_name":"Respiratory distress syndrome in the newborn","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Survanta","generic_name":"BERACTANT","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"","drug_class":"Surfactant [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"lucinactant","indication_name":"Respiratory distress syndrome in the newborn","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Surfaxin","generic_name":"LUCINACTANT","company_name":"Discovery Labs","drug_phase":"marketed","molecular_target":"","drug_class":"lucinactant","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"curosurf","indication_name":"Respiratory distress syndrome in the newborn","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Curosurf","company_name":"Jean Michel Hascoet","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":9,"revenue":null,"mechanism":null},{"drug_id":"cetyl-alcohol","indication_name":"Respiratory distress syndrome in the newborn","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cetanol","generic_name":"CETYL ALCOHOL","company_name":"GSK","drug_phase":"marketed","molecular_target":"","drug_class":"cetyl alcohol","quality_score":15,"revenue":null,"mechanism":""},{"drug_id":"tyloxapol","indication_name":"Respiratory distress syndrome in the newborn","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Alevaire","generic_name":"TYLOXAPOL","company_name":"GSK","drug_phase":"marketed","molecular_target":"","drug_class":"tyloxapol","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"poractant-alfa","indication_name":"Respiratory distress syndrome in the newborn","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Curosurf","generic_name":"PORACTANT ALFA","company_name":"Chiesi Usa Inc","drug_phase":"marketed","molecular_target":"","drug_class":"Surfactant [EPC]","quality_score":40,"revenue":null,"mechanism":"Curosurf works by reducing the surface tension in the lungs, allowing for easier breathing and improving oxygenation."},{"drug_id":"survanta","indication_name":"Respiratory distress syndrome in the newborn","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Survanta","company_name":"NICHD Neonatal Research Network","drug_phase":"discontinued","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"infasurf","indication_name":"Respiratory distress syndrome in the newborn","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Infasurf","company_name":"Children's Hospital of Philadelphia","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":10,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07344714","title":"Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Mayo Clinic","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}